AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation have?
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation has 142 citations in the OpenAlex counts ScholarIQ stores.
When was AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation published?
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation has 2023 year in the ScholarIQ index.
What is the open-access status of AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation?
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation has green oa status in the ScholarIQ index.
What is the DOI of AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation?
The DOI for AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation is on the source record.
What is the PMID of AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation?
The PMID for AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation is on the source record.
What is the OpenAlex record for AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation?
The OpenAlex for AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation is on the source record.